Core Laboratories: A Speculative Buy At Present Levels (NYSE:CLB)
Core Laboratories has just come through an awful quarter and its shares are reflective of that. See why I rate CLB stock a speculative Buy.
Stay updated with breaking news from Core Lab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Core Laboratories has just come through an awful quarter and its shares are reflective of that. See why I rate CLB stock a speculative Buy.
Schaumburg, IL (PRWEB) August 08, 2022 -- HeartcoR Solutions, a leading ECG Core Lab provider that delivers ‘round the clock clinical research for cardiac
CLB earnings call for the period ending June 30, 2022.
An interview with Jason Nolan, the man behind the Kickstarter bringing Allen Strange's seminal text back into the hands of modular synthesizer enthusiasts.
/PRNewswire/ -- Core Laboratories N.V. (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") ("Core", "Core Lab", or the "Company") reported second quarter 2022...